NCT05581225View on ClinicalTrials.gov

Prediction of Progression of Retinal Ischemia in Diabetes

Active, not recruitingOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

February 2, 2024

Study Completion Date

October 31, 2028

Conditions
Diabetic Retinopathy
Trial Locations (1)

3000-548

AIBILI-CEC (AIBILI- Clinical Trials Centre), Coimbra

All Listed Sponsors
lead

Association for Innovation and Biomedical Research on Light and Image

OTHER

NCT05581225 - Prediction of Progression of Retinal Ischemia in Diabetes | Biotech Hunter | Biotech Hunter